About: Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
source	Medline; PMC
abstract	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate, and capacity to overwhelm healthcare systems [1, 2]. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmission [3–5].
has issue date	2020-05-26(xsd:dateTime)
bibo:doi	10.1183/13993003.01398-2020
bibo:pmid	32457198
has license	cc-by-nc
sha1sum (hex)	be9df10049c884003b9ca2bb11e893cc5ade98c9
schema:url	https://doi.org/10.1183/13993003.01398-2020
resource representing a document's title	Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
has PubMed Central identifier	PMC7251245
has PubMed identifier	32457198
schema:publication	Eur Respir J
resource representing a document's body	covid:be9df10049c884003b9ca2bb11e893cc5ade98c9#body_text
is schema:about of	named entity 'tuberculosis' named entity 'co-infection' named entity 'vaccination' named entity 'differential diagnosis' named entity 'hypertension' named entity 'sequelae' named entity 'infection' named entity 'COVID-19' named entity 'COVID-19' named entity 'co-infection' named entity 'infection' named entity 'sequelae' named entity 'pathogenesis' named entity 'latent TB' named entity 'COVID' named entity 'COVID-19' named entity 'sequelae' named entity 'SARS-CoV-2' named entity 'HIV' named entity 'COVID' named entity 'infection' named entity 'sample size' named entity 'HRCT' named entity 'COPD' named entity 'comorbidities' named entity 'latently infected' named entity 'COVID' named entity 'COVID' named entity 'COVID-19' named entity 'drug-drug interactions' named entity 'liver' named entity 'epidemic' named entity 'BCG' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'clinical evaluation' named entity 'COVID' named entity 'COVID-19' named entity 'bacillus Calmette-Guérin' named entity 'kidney diseases' named entity 'index of suspicion' named entity 'TB treatment' named entity 'risk factors' named entity 'COVID' named entity 'intensive care unit' named entity 'unilateral or bilateral' named entity 'statistically significant' named entity 'sequelae' named entity 'COVID' named entity 'Active tuberculosis' named entity 'cohort' named entity 'sequelae' named entity 'cases' named entity 'co-infection' named entity 'Active' named entity 'COVID-19' named entity 'CO-INFECTION' named entity 'CASES' named entity 'SEQUELAE' named entity 'ACTIVE TUBERCULOSIS' named entity 'COHORT' named entity 'COVID-19'
is part of of	covid:be9df10049c884003b9ca2bb11e893cc5ade98c9#body_text The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread, clinical severity, high mortality rate, and capacity to overwhelm healthcare systems [1, 2]. SARS-CoV-2 transmission occurs mainly through droplets, although surface contamination contributes and debate continues on aerosol transmission [3–5]. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software